Abstract

MHRA drug safety update: risk of Fournier’s gangrene with SGLT2 inhibitors for diabetes

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Raising awareness of the link between sodium glucose co-transporter 2 inhibitors and euglycaemic diabetic ketoacidosis – an important perioperative consideration
Andrew Richardson
BJA Open | VOL. 4
Andrew RichardsonAndrew Richardson
01 Oct 2022
Adecuación de la seguridad del metamizol y agranulocitosis
Cristina Garcia Del Campo ... Vicente Palop Larrea
Atencion Primaria | VOL. 53
Cristina Garcia Del Campo, et. al.Cristina Garcia Del Campo ... Vicente Palop Larrea
03 Apr 2021
Comparison of New Oral Hypoglycemic Agents on Risk of Urinary Tract and Genital Infections in Type2 Diabetes: A Network Meta-analysis.
Xujie Wang ... Yi Wang
Advances in therapy | VOL. 38
Xujie Wang, et. al.Xujie Wang ... Yi Wang
17 May 2021
A safety update on sodium glucose co-transporter 2 inhibitors.
David Fitchett
Diabetes, obesity & metabolism | VOL. Suppl 21 2
David FitchettDavid Fitchett
01 Apr 2019
View more papers

More From: Drug and Therapeutics Bulletin

Paper Title
Journal
Date
Author
▼Ritlecitinib for severe alopecia areata
-
Drug and Therapeutics Bulletin | VOL. 62
--
29 May 2024
Update patients on gonadal and fetal shielding for diagnostic imaging
Joanna Girling
Drug and Therapeutics Bulletin | VOL. -
Joanna GirlingJoanna Girling
15 May 2024
Pharmaceutical company payments to NHS trusts
-
Drug and Therapeutics Bulletin | VOL. 62
--
06 May 2024
Increasing awareness of the risk of death from a propanolol overdose
-
Drug and Therapeutics Bulletin | VOL. -
--
02 May 2024
View more papers